Suppr超能文献

单体轻链可变结构域形成淀粉样纤维。

Formation of amyloid fibers by monomeric light chain variable domains.

作者信息

Brumshtein Boris, Esswein Shannon R, Landau Meytal, Ryan Christopher M, Whitelegge Julian P, Phillips Martin L, Cascio Duilio, Sawaya Michael R, Eisenberg David S

机构信息

From the Departments of Biological Chemistry and Chemistry and Biochemistry, Howard Hughes Medical Institute, UCLA-Department of Energy (DOE) Institute for Genomics and Proteomics, UCLA, Los Angeles, California 90095 and.

the Pasarow Mass Spectrometry Laboratory, NPI-Semel Institute, David Geffen School of Medicine, UCLA, Los Angeles, California 90025.

出版信息

J Biol Chem. 2014 Oct 3;289(40):27513-25. doi: 10.1074/jbc.M114.585638. Epub 2014 Aug 19.

Abstract

Systemic light chain amyloidosis is a lethal disease characterized by excess immunoglobulin light chains and light chain fragments composed of variable domains, which aggregate into amyloid fibers. These fibers accumulate and damage organs. Some light chains induce formation of amyloid fibers, whereas others do not, making it unclear what distinguishes amyloid formers from non-formers. One mechanism by which sequence variation may reduce propensity to form amyloid fibers is by shifting the equilibrium toward an amyloid-resistant quaternary structure. Here we identify the monomeric form of the Mcg immunoglobulin light chain variable domain as the quaternary unit required for amyloid fiber assembly. Dimers of Mcg variable domains remain stable and soluble, yet become prone to assemble into amyloid fibers upon disassociation into monomers.

摘要

系统性轻链淀粉样变性是一种致命疾病,其特征是存在过量的免疫球蛋白轻链以及由可变结构域组成的轻链片段,这些片段聚集成淀粉样纤维。这些纤维会积累并损害器官。一些轻链会诱导淀粉样纤维的形成,而另一些则不会,这使得尚不清楚能区分形成淀粉样蛋白的轻链和不形成淀粉样蛋白的轻链的因素是什么。序列变异可能降低形成淀粉样纤维倾向的一种机制是将平衡转向抗淀粉样蛋白的四级结构。在这里,我们确定Mcg免疫球蛋白轻链可变结构域的单体形式是淀粉样纤维组装所需的四级单元。Mcg可变结构域的二聚体保持稳定且可溶,但在解离成单体后易于组装成淀粉样纤维。

相似文献

1
Formation of amyloid fibers by monomeric light chain variable domains.
J Biol Chem. 2014 Oct 3;289(40):27513-25. doi: 10.1074/jbc.M114.585638. Epub 2014 Aug 19.
2
A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
J Mol Biol. 2010 Feb 19;396(2):280-92. doi: 10.1016/j.jmb.2009.11.038. Epub 2009 Nov 24.
3
Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
FEBS J. 2017 Sep;284(18):3114-3127. doi: 10.1111/febs.14181. Epub 2017 Aug 13.
4
Effect of O-glycosylation on amyloid fibril formation of the variable domain in the Vλ6 light chain mutant Wil.
Int J Biol Macromol. 2021 Jan 1;166:342-351. doi: 10.1016/j.ijbiomac.2020.10.194. Epub 2020 Oct 28.
5
Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation.
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9490-4. doi: 10.1073/pnas.92.21.9490.
7
Effect of single point mutations in a form of systemic amyloidosis.
Protein Sci. 2015 Sep;24(9):1451-62. doi: 10.1002/pro.2730. Epub 2015 Jul 14.
9
Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity.
Biochemistry. 1999 Oct 19;38(42):14101-8. doi: 10.1021/bi991131j.

引用本文的文献

1
SAAINT-DB: a comprehensive structural antibody database for antibody modeling and design.
Acta Pharmacol Sin. 2025 Jun 30. doi: 10.1038/s41401-025-01608-5.
2
Structural, Biophysical, and Computational Studies of a Murine Light Chain Dimer.
Molecules. 2024 Jun 18;29(12):2885. doi: 10.3390/molecules29122885.
3
Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.
Int J Mol Sci. 2024 Jan 27;25(3):1593. doi: 10.3390/ijms25031593.
6
Understanding AL amyloidosis with a little help from models.
Front Immunol. 2022 Nov 15;13:1008449. doi: 10.3389/fimmu.2022.1008449. eCollection 2022.
7
Donor-strand exchange drives assembly of the TasA scaffold in Bacillus subtilis biofilms.
Nat Commun. 2022 Nov 18;13(1):7082. doi: 10.1038/s41467-022-34700-z.
10
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.
J Biol Chem. 2020 Dec 4;295(49):16572-16584. doi: 10.1074/jbc.RA120.013461. Epub 2020 Sep 20.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Systemic amyloidoses.
Annu Rev Biochem. 2013;82:745-74. doi: 10.1146/annurev-biochem-072611-130030. Epub 2013 Feb 28.
3
The amyloid state of proteins in human diseases.
Cell. 2012 Mar 16;148(6):1188-203. doi: 10.1016/j.cell.2012.02.022.
4
β₂-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages.
Nat Struct Mol Biol. 2011 Jan;18(1):49-55. doi: 10.1038/nsmb.1948. Epub 2010 Dec 5.
5
A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.
Structure. 2010 May 12;18(5):563-70. doi: 10.1016/j.str.2010.02.012.
6
XDS.
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32. doi: 10.1107/S0907444909047337. Epub 2010 Jan 22.
7
A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis.
J Mol Biol. 2010 Feb 19;396(2):280-92. doi: 10.1016/j.jmb.2009.11.038. Epub 2009 Nov 24.
9
Light chain amyloidosis - current findings and future prospects.
Curr Protein Pept Sci. 2009 Oct;10(5):500-508. doi: 10.2174/138920309789351949.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验